Scott Sheren, MD
Ophthalmology · Riverhead, NYNPI 1225070378
Payments from drug & device makers
What this record shows
This record is dominated by speaking fees: $26 of the $42 with a category attached, or 60.4%. Every reported general payment came from a single manufacturer, Rxsight Inc. That places this record below the midpoint for ophthalmology clinicians in NY, where the typical reported total is $1,047.
Across 2 payments — averaging $21.19 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Rxsight Inc$42
What the payments were for
- Speaking & faculty fees$2660%
- Food & beverage$1740%
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Rxsight Inc | 2 | $42 |
How this compares
$42 in reported general payments places this provider in the 10th percentile of 1,587 ophthalmology providers in New York.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| RestasisCyclosporine | 59 | $95,083 |
| InveltysLoteprednol Etabonate | 257 | $74,303 |
| ProlensaBromfenac Sodium | 241 | $69,660 |
| LumiganBimatoprost | 77 | $52,914 |
| XiidraLifitegrast | 20 | $27,722 |
| RocklatanNetarsudil Mesylat/Latanoprost | 49 | $27,428 |
| RhopressaNetarsudil Mesylate | 50 | $26,895 |
| Gatifloxacin | 575 | $21,094 |
| IlevroNepafenac | 56 | $20,371 |
| Cyclosporine | 21 | $17,047 |
| Travoprost | 62 | $16,729 |
| Brinzolamide | 61 | $15,083 |
| Prednisolone Acetate | 389 | $12,543 |
| Latanoprost | 794 | $10,809 |
| Bromfenac Sodium | 44 | $9,520 |
Paid to pharmacies, not to this prescriber.
Other ophthalmology in Riverhead
- David RubaltelliBrooklyn$8.9M
- Nathan RadcliffeNew York$2.1M
- Richard SpaideNew York$1.7M
- Eric DonnenfeldGarden City$1.4M
- Marguerite McDonaldOceanside$893K
- Joshua YoungNew York$814K
- David KleinmanRochester$730K
- Jonathan JonischGreat Neck$726K
- Joseph PanarelliNew York$541K
- Eric RosenbergNew York$434K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.